2017Traditional Chinese MedicineRequires access

Clinical study on treatment of pulmonary heart disease with pulmonary Qi deficiency syndrome by the Bufei-Zhengqi decoction and acupoint application combined with western medicine

Y Liu

Open publisher page 0 citations

Abstract

Objective To explore the effect of Babu patch combined with Bufei-Zhengqi decoction on lung function and immunological indexes of pulmonary heart disease with Fei qi deficiency. Methods A total of 100 patients with pulmonary heart disease were randomly divided into study group and control group, 50 in each group. The control group was treated with routine therapy, the study group was treated with routine therapy and integrated Chinese medicine therapy (Babu patch combined with Bufei-Zhengqi decoction). Both groups were treated for 8 weeks. The effect of the two groups, and the lung function index, immunological indexes and adverse reaction were evaluated. Results The total effective rate in study group was 96.0% (48/50), the total effective rate in control group 84.0% (42/50), and there was significantly higher than that of the control group (χ2=8.130, P=0.043). After treatment, the lung function indexes FEV1 (65.26% ± 5.34% vs. 61.52% ± 6.21%, t=3.229), FEV1/FVC (67.59% ± 5.86% vs. 64.68% ± 5.52%, t=2.556) of study group were significantly higher than those of the control group (P<0.05). The IgA (2.37 ± 0.53 g/L vs. 1.83 ± 0.76 g/L, t=4.121) in study group were significantly higher than the control group (P<0.01). Conclusions The application of Babu patch combined with Bufei-Zhengqi decoction therapy, meet the requirements of treatment, improve lung function and immune function. Key words: Pulmonary heart disease; Bufei-Zhengqi decoction; Acupoint sticking therapy; Clinical study

About this research paper

What this paper is about

Objective To explore the effect of Babu patch combined with Bufei-Zhengqi decoction on lung function and immunological indexes of pulmonary heart disease with Fei qi deficiency. Methods A total of 100 patients with pulmonary heart disease were randomly divided into study group and control group, 50 in each group. The control group was treated with routine therapy, the study group was treated with routine therapy and integrated Chinese medicine therapy (Babu patch combined with Bufei-Zhengqi decoction). Both groups were treated for 8 weeks. The effect of the two groups, and the lung function index, immunological indexes and adverse reaction were evaluated. Results The total effective rate in study group was 96.0% (48/50), the total effective rate in control group 84.0% (42/50), and there was significantly higher than that of the control group (χ2=8.130, P=0.043). After treatment, the lung function indexes FEV1 (65.26% ± 5.34% vs. 61.52% ± 6.21%, t=3.229), FEV1/FVC (67.59% ± 5.86% vs. 64.68% ± 5.52%, t=2.556) of study group were significantly higher than those of the control group (P<0.05). The IgA (2.37 ± 0.53 g/L vs. 1.83 ± 0.76 g/L, t=4.121) in study group were significantly higher than the control group (P<0.01). Conclusions The application of Babu patch combined with Bufei-Zhengqi decoction therapy, meet the requirements of treatment, improve lung function and immune function. Key words: Pulmonary heart disease; Bufei-Zhengqi decoction; Acupoint sticking therapy; Clinical study

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of Babu patch combined with Bufei-Zhengqi decoction on lung function and immunological indexes of pulmonary heart disease with Fei qi deficiency. Methods A total of 100 patients with pulmonary heart disease were randomly divided into study group and control group, 50 in each group. The control group was treated with routine therapy, the study group was treated with routine therapy and integrated Chinese medicine therapy (Babu patch combined with Bufei-Zhengqi decoction). Both groups were treated for 8 weeks. The effect of the two groups, and the lung function index, immunological indexes and adverse reaction were evaluated. Results The total effective rate in study group was 96.0% (48/50), the total effective rate in control group 84.0% (42/50), and there was significantly higher than that of the control group (χ2=8.130, P=0.043). After treatment, the lung function indexes FEV1 (65.26% ± 5.34% vs. 61.52% ± 6.21%, t=3.229), FEV1/FVC (67.59% ± 5.86% vs. 64.68% ± 5.52%, t=2.556) of study group were significantly higher than those of the control group (P<0.05). The IgA (2.37 ± 0.53 g/L vs. 1.83 ± 0.76 g/L, t=4.121) in study group were significantly higher than the control group (P<0.01). Conclusions The application of Babu patch combined with Bufei-Zhengqi decoction therapy, meet the requirements of treatment, improve lung function and immune function. Key words: Pulmonary heart disease; Bufei-Zhengqi decoction; Acupoint sticking therapy; Clinical study

Key concepts: Medicine, Decoction, Traditional Chinese medicine, Internal medicine, Gastroenterology, Pulmonary function testing, Lung, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study on treatment of pulmonary heart disease with pulmonary Qi deficiency syndrome by the Bufei-Zhengqi decoction and acupoint application combined with western medicine — Research Paper | ScholarLens